The DOI matches its Crossref record; 68 of the 68 references it cites were found in a registry or an index.
Role of Hypoxia-inducible Factor-1 in Transcriptional Activation of Ceruloplasmin by Iron Deficiency
Open accessAbstract
A role of the copper protein ceruloplasmin (Cp) in iron metabolism is suggested by its ferroxidase activity and by the tissue iron overload in hereditary Cp deficiency patients. In addition, plasma Cp increases markedly in several conditions of anemia, e.g. iron deficiency, hemorrhage, renal failure, sickle cell disease, pregnancy, and inflammation. However, little is known about the cellular and molecular mechanism(s) involved. We have reported that iron chelators increase Cp mRNA expression and protein synthesis in human hepatocarcinoma HepG2 cells. Furthermore, we have shown that the increase in Cp mRNA is due to increased rate of transcription. We here report the results of new studies designed to elucidate the molecular mechanism underlying transcriptional activation of Cp by iron deficiency. The 5'-flanking region of the Cp gene was cloned from a human genomic library. A 4774-base pair segment of the Cp promoter/enhancer driving a luciferase reporter was transfected into HepG2 or Hep3B cells. Iron deficiency or hypoxia increased luciferase activity by 5-10-fold compared with untreated cells. Examination of the sequence showed three pairs of consensus hypoxia-responsive elements (HREs). Deletion and mutation analysis showed that a single HRE was necessary and sufficient for gene activation. The involvement of hypoxia-inducible factor-1 (HIF-1) was shown by gel-shift and supershift experiments that showed HIF-1alpha and HIF-1beta binding to a radiolabeled oligonucleotide containing the Cp promoter HRE. Furthermore, iron deficiency (and hypoxia) did not activate Cp gene expression in Hepa c4 hepatoma cells deficient in HIF-1beta, as shown functionally by the inactivity of a transfected Cp promoter-luciferase construct and by the failure of HIF-1 to bind the Cp HRE in nuclear extracts from these cells. These results are consistent with in vivo findings that iron deficiency increases plasma Cp and provides a molecular mechanism that may help to understand these observations.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Semenza, G. L., & Wang, G. L. (1992) · Molecular and Cellular Biology · doi:10.1128/mcb.12.12.5447 · Cited by 2,617
Role of HIF-1α in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis
Carmeliet, P., Dor, Y., Herbert, J.-M., Fukumura, D., Brusselmans, K., Dewerchin, M., Neeman, M., Bono, F., Abramovitch, R., Maxwell, P., et al. (1998) · Nature · doi:10.1038/28867 · Cited by 2,502
Cellular and developmental control of O 2 homeostasis by hypoxia-inducible factor 1α
Iyer, N. V., Kotch, L. E., Agani, F., Leung, S. W., Laughner, E., Wenger, R. H., Gassmann, M., Gearhart, J. D., Lawler, A. M., Yu, A. Y., et al. (1998) · Genes & Development · doi:10.1101/gad.12.2.149 · Cited by 2,476
Transcriptional regulation of genes encoding glycolytic enzymes by hypoxia-inducible factor 1.
Semenza, G., Roth, P. H., Fang, H. M., & Wang, G. L. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)31580-6 · Cited by 1,892
Semenza, G. L., Jiang, B.-H., Leung, S. W., Passantino, R., Concordet, J.-P., Maire, P., & Giallongo, A. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.51.32529 · Cited by 1,752
HIF‐1α is required for solid tumor formation and embryonic vascularization
Ryan, H. E., Lo, J., & Johnson, R. S. (1998) · The EMBO Journal · doi:10.1093/emboj/17.11.3005 · Cited by 1,579
Métézeau, P. (1998) · Research in Microbiology · doi:10.1016/s0923-2508(98)80442-7 · Cited by 1,254
Regulating the fate of mRNA: the control of cellular iron metabolism
Klausner, R. D., Rouault, T. A., & Harford, J. B. (1993) · Cell · doi:10.1016/0092-8674(93)90046-s · Cited by 1,210
Hypoxia-inducible factor 1: master regulator of O2 homeostasis
Semenza, G. L. (1998) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(98)80016-6 · Cited by 1,092
Vulpe, C. D., Kuo, Y.-M., Murphy, T. L., Cowley, L., Askwith, C., Libina, N., Gitschier, J., & Anderson, G. J. (1999) · Nature Genetics · doi:10.1038/5979 · Cited by 1,084
Flagged first, then by citations
Research works printed but not linked: 13
- Warburg, 1927, Biochem. Z., 190, 143
- Venakteshwara Rao, 1975, J. Assoc. Physicians India, 23, 571
- Iwanska, 1978, Acta Physiol. Pol., 29, 465
- Taylor, 1994, Clin. Nephrol., 41, 297
- Kalra, 1989, Indian J. Pathol. Microbiol., 32, 28
- Barik, 1993, 15, 277
- Chen, 1993, Mol. Cell. Biol., 13, 6766
- Wenger, 1997, Biol. Chem., 378, 609
- Semenza, 1992, Mol. Cell. Biol., 12, 5447
- Shimizu, 1982, Acta Haematol. Jpn., 45, 1183
- Morita, 1992, Clin. Neurol., 32, 483
- Pedersen, 1987, Eur. J. Respir. Dis., 70, 140
- Linder, 1981, J. Natl. Cancer Inst., 67, 263
Cited by
Sorted by citations
Items 101–200 of 275
PAX8 activates metabolic genes via enhancer elements in Renal Cell Carcinoma
Bleu, M., Gaulis, S., Lopes, R., Sprouffske, K., Apfel, V., Holwerda, S. J. B., Pregnolato, M., Yildiz, U., Cordo’, V., Dost, A. F. M., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-11672-1 · Cited by 69
Anemia upregulates lipocalin 2 in the liver and serum
蒋文雷, Constante, M., & Santos, M. M. (2008) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2008.04.006 · Cited by 68
Haque, M., Wang, V. E. H., Davis, D. A., Zheng, Z., & Yarchoan, R. (2006) · Journal of Virology · doi:10.1128/jvi.00553-06 · Cited by 68
Hypoxic up-regulation of erythroid 5-aminolevulinate synthase
Höfer, T., Wenger, R. H., Kramer, M. F., Ferreira, G. C., & Gassmann, M. (2002) · Blood · doi:10.1182/blood-2002-03-0773 · Cited by 66
Prolyl hydroxylase domain enzymes: important regulators of cancer metabolism
Pollard, P. J., Yang, M. H., Su, H., Soga, T., & Kranc, K. R. (2014) · Hypoxia · doi:10.2147/hp.s47968 · Cited by 66
Höpfl, G., Ogunshola, O. O., & Gassmann, M. (2003) · Advances in experimental medicine and biology · doi:10.1007/978-1-4419-8997-0_7 · Cited by 67
Therapeutic targeting of the HIF oxygen-sensing pathway: Lessons learned from clinical studies
Haase, V. H. (2017) · Experimental Cell Research · doi:10.1016/j.yexcr.2017.05.004 · Cited by 65
Divalent metal transporter 1 is a hypoxia‐inducible gene
Qian, Z., Wu, X. M., Fan, M., Yang, L., Du, F., Yung, W., & Ke, Y. (2010) · Journal of Cellular Physiology · doi:10.1002/jcp.22485 · Cited by 64
Effects of development and iron status on ceruloplasmin expression in rat brain
Chang, Y. Z., Qian, Z., Wang, K., Zhu, L., Yang, X. D., Du, J. R., Jiang, L. H., Ho, K. P., Wang, Q., & Ke, Y. (2005) · Journal of Cellular Physiology · doi:10.1002/jcp.20321 · Cited by 64
Iron elevations in the aging Parkinsonian brain: a consequence of impaired iron homeostasis?
Lee, D. W., & Andersen, J. K. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06470.x · Cited by 63
The oxygen sensing signal cascade under the influence of reactive oxygen species
Acker, H. (2005) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2005.1760 · Cited by 63
Singh, A. K., Mukhopadhyay, C., Biswas, S., Singh, V. K., & Mukhopadhyay, C. K. (2012) · PLoS ONE · doi:10.1371/journal.pone.0038489 · Cited by 59
Self-citationIdentification of Chemical Compounds that Induce HIF-1α Activity
Xia, M., Huang, R., Sun, Y., Semenza, G. L., Aldred, S. F., Witt, K. L., Inglese, J., Tice, R. R., & Austin, C. P. (2009) · Toxicological Sciences · doi:10.1093/toxsci/kfp123 · Cited by 59
Hypoxia-inducible factor 1, a master transcription factor of cellular hypoxic gene expression
Hirota, K. (2002) · Journal of Anesthesia · doi:10.1007/s005400200011 · Cited by 59
Gao, N., Nester, R. A., & Sarkar, M. A. (2004) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2003.12.002 · Cited by 58
Biswas, S., Gupta, M. K., Chattopadhyay, D., & Mukhopadhyay, C. K. (2006) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00718.2006 · Cited by 57
Self-citationPrognostic Value of Elevated Serum Ceruloplasmin Levels in Patients With Heart Failure
Hammadah, M., Fan, Y., Wu, Y., Hazen, S. L., & Tang, W. H. W. (2014) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2014.08.001 · Cited by 55
Expression of ferroportin1, hephaestin and ceruloplasmin in rat heart
Qian, Z., Chang, Y. Z., Leung, G., Du, J. R., Zhu, L., Wang, Q. L., Niu, L., Xu, Y. J., Yang, L., Ho, K. P., et al. (2007) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2007.02.006 · Cited by 55
Wenger, R. H., & Kurtz, A. (2011) · Comprehensive physiology · doi:10.1002/cphy.c100075 · Cited by 55
Wu, Y., Terekhanova, N. V., Caravan, W., Deen, N. N. A., Lal, P., Chen, S., Mo, C.-K., Cao, S., Li, Y., Karpova, A. Y., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-37211-7 · Cited by 60
Tapryal, N., Mukhopadhyay, C., Das, D., Fox, P. L., & Mukhopadhyay, C. K. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m804079200 · Cited by 54
Self-citationSugahara, M., Tanaka, T., & Nangaku, M. (2022) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2022.108272 · Cited by 52
Anemia and impaired stress-induced erythropoiesis in aceruloplasminemic mice
Cherukuri, S., Tripoulas, N. A., Nurko, S., & Fox, P. L. (2004) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2004.07.003 · Cited by 52
Self-citationAv, S., Zakahrova, E. T., Kostevich, V. A., Самыгина, В. Р., & Vasilyev, V. B. (2014) · BioMetals · doi:10.1007/s10534-014-9755-2 · Cited by 51
Biswas, S., Tapryal, N., Mukherjee, R., Kumar, R., & Mukhopadhyay, C. K. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2012.11.003 · Cited by 50
Self-citationHIF stabilizers in the management of renal anemia: from bench to bedside to pediatrics
Kular, D., & Macdougall, I. C. (2018) · Pediatric Nephrology · doi:10.1007/s00467-017-3849-3 · Cited by 50
Jolliff, J. S., & Mahan, D. C. (2011) · Journal of Animal Science · doi:10.2527/jas.2010-3736 · Cited by 50
Iron metabolism in the eye: A review
Goralska, M., Ferrell, J., Harned, J., Lall, M. M., Nagar, S., Fleisher, L. N., & McGahan, M. C. (2008) · Experimental Eye Research · doi:10.1016/j.exer.2008.10.026 · Cited by 49
Protein degradation and iron homeostasis
Thompson, J. W., & Bruick, R. K. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2012.02.003 · Cited by 49
Xie, L., & Collins, J. F. (2011) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00023.2011 · Cited by 48
Hudson, D. M., Curtis, S. B., Smith, V. C., Griffiths, T. A. M., Wong, A. Y. K., Scudamore, C. H., Buchan, A. M. J., & MacGillivray, R. T. A. (2009) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00453.2009 · Cited by 48
HIF-1α is neuroprotective during the early phases of mild hypoxia in rat cortical neurons
López‐Hernández, B., Posadas, I., Podlesniy, P., Abad, M. A., Trullás, R., & Ceña, V. (2011) · Experimental Neurology · doi:10.1016/j.expneurol.2011.11.040 · Cited by 47
Expression of a membrane‐bound form of the ferroxidase ceruloplasmin by leptomeningeal cells
Mittal, B., Doroudchi, M. M., Jeong, S. Y., Patel, B. N., & David, S. (2003) · Glia · doi:10.1002/glia.10158 · Cited by 47
Kotarsky, H., Karikoski, R., Mörgelin, M., Marjavaara, S. K., Bergman, P., Zhang, D., Smet, J., Coster, R. V., & Fellman, V. (2010) · Mitochondrion · doi:10.1016/j.mito.2010.05.009 · Cited by 46
Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors and Iron Metabolism
Ogawa, C., Tsuchiya, K., & Maeda, K. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24033037 · Cited by 45
Sadaghianloo, N., Contenti, J., Dardik, A., & Mazure, N. M. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20215387 · Cited by 45
Zakharova, E. T., Kostevich, V. A., Av, S., & Vasilyev, V. B. (2012) · BioMetals · doi:10.1007/s10534-012-9586-y · Cited by 45
Hypoxic preconditioning increases iron transport rate in astrocytes
Yang, L., Fan, M., Du, F., Gong, Q., Bi, Z. G., Zhu, Z. J., Zhu, L., & Ke, Y. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2011.12.004 · Cited by 44
Matsuoka, R., Shiba‐Ishii, A., Nakano, N., Togayachi, A., Sakashita, S., Sato, Y., Minami, Y., & Noguchi, M. (2018) · Lung Cancer · doi:10.1016/j.lungcan.2018.01.012 · Cited by 44
FAT1 is a novel upstream regulator of HIF1α and invasion of high grade glioma
Madan, E., Dikshit, B., Gowda, S. H., Srivastava, C., Sarkar, C., Chattopadhyay, P., Sinha, S., & Chosdol, K. (2016) · International Journal of Cancer · doi:10.1002/ijc.30386 · Cited by 43
Superoxide dismutase 1 modulates expression of transferrin receptor
Danzeisen, R., Achsel, T., Bederke, U., Cozzolino, M., Crosio, C., Ferri, A., Frenzel, M., Gralla, E. B., Huber, L., Ludolph, A. C., et al. (2006) · JBIC Journal of Biological Inorganic Chemistry · doi:10.1007/s00775-006-0099-4 · Cited by 41
Güleç, Ş., & Collins, J. F. (2013) · PLoS ONE · doi:10.1371/journal.pone.0066010 · Cited by 40
di Patti, M. C. B., Persichini, T., Mazzone, V., Polticelli, F., Colasanti, M., & Musci, G. (2004) · Neuroscience Letters · doi:10.1016/j.neulet.2004.04.005 · Cited by 40
Gao, S., Zhou, J., Zhao, Y., Toselli, P. A., & Li, W. (2012) · Toxicological Sciences · doi:10.1093/toxsci/kfs327 · Cited by 40
Current Understanding of HIF in Renal Disease
Rosenberger, C., Rosen, S., & Heyman, S. N. (2005) · Kidney & Blood Pressure Research · doi:10.1159/000090187 · Cited by 39
Breakthrough science: hypoxia-inducible factors, oxygen sensing, and disorders of hematopoiesis
Semenza, G. L. (2021) · Blood · doi:10.1182/blood.2021011043 · Cited by 38
Lukiw, W. J., Gordon, W. C., Rogaev, E. I., Thompson, H. W., & Bazan, N. G. (2001) · Neuroreport · doi:10.1097/00001756-200101220-00019 · Cited by 38
Wanyin, W., Liwei, D., Lin, J., Hailiang, X., Chang-quan, L., & Li, M. (2011) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2010.12.015 · Cited by 38
Das, D., Tapryal, N., Goswami, S. K., Fox, P. L., & Mukhopadhyay, C. K. (2007) · Biochemical Journal · doi:10.1042/bj20060963 · Cited by 37
Self-citationLivesey, K., Wimhurst, V. L. C., Carter, K., Worwood, M., Cadet, E., Rochette, J., Roberts, A. G., Pointon, J. J., Merryweather-Clarke, A. T., Bassett, M. L., et al. (2004) · Journal of Medical Genetics · doi:10.1136/jmg.2003.008805 · Cited by 37
Biological role of copper as an essential trace element in the human organism
Pavelková, M., Vysloužil, J., Kubová, K., & Vetchý, D. (2018) · Česká a slovenská farmacie · doi:10.36290/csf.2018.021 · Cited by 35
Huffman, J. L., Mokashi, A., Bächinger, H. P., & Brennan, R. G. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m105675200 · Cited by 35
Selective Activation of Ceruloplasmin Promoter in Ovarian Tumors
Lee, C. M., Lo, H., Shao, R., Wang, S., Xia, W., Gershenson, D. M., & Hung, M. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-2551 · Cited by 35
Triad role of hepcidin, ferroportin, and Nrf2 in cardiac iron metabolism: From health to disease
Jayakumar, D., Narasimhan, K. K. S., & Kalaiselvi, P. (2021) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2021.126882 · Cited by 34
Dual Role of Insulin in Transcriptional Regulation of the Acute Phase Reactant Ceruloplasmin
Seshadri, V., Fox, P. L., & Mukhopadhyay, C. K. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m203610200 · Cited by 34
Self-citationConti, A., Iannaccone, S., Sferrazza, B., Monte, L. B. D., Cappa, S. F., Franciotta, D. M., Olivieri, S., & Alessio, M. (2008) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1002/prca.200780081 · Cited by 33
Schwantes, A., Wickert, A., Becker, S. A., Baer, P. C., Weigert, A., Brüne, B., & Fuhrmann, D. C. (2024) · Redox Biology · doi:10.1016/j.redox.2024.103093 · Cited by 32
Effect of hypoxia on the binding and subcellular distribution of iron regulatory proteins
Christova, T. Y., & Templeton, D. M. (2007) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-006-9393-2 · Cited by 32
Compromised JMJD6 Histone Demethylase Activity Affects VHL Gene Repression in Preeclampsia
Alahari, S., Post, M., Rolfo, A., Weksberg, R., & Caniggia, I. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-02197 · Cited by 31
Hatakeyama, K., Ohshima, K., Nagashima, T., Ohnami, S., Ohnami, S., Serizawa, M., Shimoda, Y., Maruyama, K., Akiyama, Y., Urakami, K., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-26967-4 · Cited by 30
A novel iron chelator that does not induce HIF-1 activity
Creighton-Gutteridge, M., & Tyrrell, R. M. (2002) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(02)00884-5 · Cited by 30
Treatment of Anemia in Kidney Disease: Beyond Erythropoietin
Wish, J. B. (2021) · Kidney International Reports · doi:10.1016/j.ekir.2021.05.028 · Cited by 29
Biochemistry and Molecular Biology of Copper in Mammals
Linder, M. C. (2002) · Humana Press eBooks · doi:10.1007/978-1-59259-288-3_1 · Cited by 29
Ogawa, C., Tsuchiya, K., Tomosugi, N., & Maeda, K. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21197153 · Cited by 29
(Z)-ligustilide increases ferroportin1 expression and ferritin content in ischemic SH-SY5Y cells
Zhang, Y., Li, F.-M., Guo, Y., Jiang, L., Ma, J., Ke, Y., & Qian, Z. (2016) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2016.10.029 · Cited by 28
Hypoxia-inducible factor-1: A possible link between inhalational anesthetics and tumor progression?
Zhao, H., Iwasaki, M., Yang, J., Savage, S., & Ma, D. (2014) · Acta anaesthesiologica Taiwanica · doi:10.1016/j.aat.2014.05.008 · Cited by 28
Strategies to Interfere with Tumor Metabolism through the Interplay of Innate and Adaptive Immunity
Mora, J., Mertens, C., Meier, J. K., Fuhrmann, D. C., Brüne, B., & Jung, M. (2019) · Cells · doi:10.3390/cells8050445 · Cited by 27
Iron metabolism in mammalian cells
Walker, B., Tiong, J., & Jefferies, W. A. (2001) · International review of cytology · doi:10.1016/s0074-7696(01)11020-x · Cited by 27
Transcriptional regulation of ceruloplasmin by an IL-6 response element pathway
Conley, L., Geurs, T. L., & Levin, L. A. (2005) · Molecular Brain Research · doi:10.1016/j.molbrainres.2005.05.027 · Cited by 27
Ceruloplasmin Induces Polymorphonuclear Leukocyte Priming in Localized Aggressive Periodontitis
Iwata, T., Kantarcı, A., Yagi, M., Jackson, T. S., Hastürk, H., Kurihara, H., & Dyke, T. E. V. (2009) · Journal of Periodontology · doi:10.1902/jop.2009.090092 · Cited by 26
Bailey, D. K., Clark, W., & Kosman, D. J. (2021) · PLoS ONE · doi:10.1371/journal.pone.0254794 · Cited by 25
Impact of Hypoxia over Human Viral Infections and Key Cellular Processes
Reyes, A., Duarte, L. F., Farías, M. A., Tognarelli, E. I., Kalergis, A. M., Bueno, S. M., & González, P. A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22157954 · Cited by 25
Lan, C. L., Ropert, M., Lainé, F., Medevielle, M., Jard, C., Pouchard, M., Treut, A. L., Moirand, R., Loréal, O., & Brissot, P. (2004) · Alcoholism Clinical and Experimental Research · doi:10.1097/01.alc.0000125341.42253.c2 · Cited by 25
Lainé, F., Ropert, M., Lan, C. L., Loréal, O., Bellissant, É., Jard, C., Pouchard, M., Treut, A. L., & Brissot, P. (2002) · Journal of Hepatology · doi:10.1016/s0168-8278(01)00254-9 · Cited by 24
Novel Regulatory Mechanisms of Pathogenicity and Virulence to Combat MDR inCandida albicans
Hameed, S., & Fatima, Z. (2013) · International Journal of Microbiology · doi:10.1155/2013/240209 · Cited by 24
Alva, R., Moradi, F., Liang, P., & Stuart, J. A. (2022) · Biomolecules · doi:10.3390/biom12111684 · Cited by 23
Biswas, S., Mukherjee, R., Tapryal, N., Singh, A. K., & Mukhopadhyay, C. K. (2013) · PLoS ONE · doi:10.1371/journal.pone.0062128 · Cited by 24
Self-citationHypoxia-Inducible Factor Stabilizers: a New Avenue for Reducing BP While Helping Hemoglobin?
Yousaf, F., & Spinowitz, B. (2016) · Current Hypertension Reports · doi:10.1007/s11906-016-0629-6 · Cited by 23
Kennedy, D. J., Fan, Y., Wu, Y., Pepoy, M. L., Hazen, S. L., & Tang, W. H. W. (2013) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.07720713 · Cited by 22
Brain Iron Dysregulation and the Risk of Ageing White Matter Lesions
Gebril, O. H., Simpson, J. E., Kirby, J., Brayne, C., & Ince, P. G. (2011) · NeuroMolecular Medicine · doi:10.1007/s12017-011-8161-y · Cited by 22
High levels of ceruloplasmin in the serum of transgenic mice developing hepatocellular carcinoma
Pousset, D., Piller, V., Bureaud, N., & Piller, F. (2001) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2001.02015.x · Cited by 21
Wish, J. B., Eckardt, K., Kovesdy, C. P., Fishbane, S. N., Spinowitz, B., & Berns, J. S. (2021) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2021.06.019 · Cited by 20
Zheng, Q., Zhang, P., Yang, H., Geng, Y., Tang, J., Kang, Y., Qi, A., & Li, S. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e15310 · Cited by 19
Lukiw, W. J. (2001) · Elsevier eBooks · doi:10.1016/b978-044450811-9/50032-x · Cited by 19
Ceruloplasmin as Redox Marker Related to Heart Failure Severity
Lazar-Poloczek, E., Romuk, E. B., Rozentryt, P., Duda, S., Gąsior, M., & Wojciechowska, C. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221810074 · Cited by 18
Sözmen, E. Y., Kavaklı, K., Çetinkaya, B., Akçay, Y., Yılmaz, D., & Aydınok, Y. (2003) · Biological Trace Element Research · doi:10.1385/bter:94:1:79 · Cited by 18
The role of hypoxia inducible factor-1 in cell metabolism – a possible target in cancer therapy
Aiba, R. S. B., Dimova, E. Y., Görlach, A., & Kietzmann, T. (2006) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.10.4.583 · Cited by 17
Tran, T. B., Ashraf, M., Jones, L., Westbrook, T., Hazegh-Azam, M., & Linder, M. C. (2002) · Journal of Nutrition · doi:10.1093/jn/132.3.351 · Cited by 16
Elliott, J. (2023) · Journal of Veterinary Pharmacology and Therapeutics · doi:10.1111/jvp.13127 · Cited by 15
Tye, S. L., Gilg, A. G., Tolliver, L. B., Wheeler, W. G., Toole, B. P., & Maria, B. L. (2008) · Journal of Child Neurology · doi:10.1177/0883073808321066 · Cited by 15
Higashijima, Y., Tanaka, T., & Nangaku, M. (2013) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2013.796358 · Cited by 14
Ceruloplasmin expression and its role in iron transport in C6 cells
Chang, Y. Z., Qian, Z., Du, J. R., Zhu, L., Xu, Y., Li, L., Wang, C., Wang, Q., Ge, X. H., Ho, K. P., et al. (2007) · Neurochemistry International · doi:10.1016/j.neuint.2007.01.004 · Cited by 14
Nguinkal, J. A., Verleih, M., Ríos‐Pérez, L. D. L., Brunner, R. M., Sahm, A., Bej, S., Rebl, A., & Goldammer, T. (2021) · Cells · doi:10.3390/cells10092289 · Cited by 13
Av, S., Kostevich, V. A., Varfolomeeva, E. Y., Grigorieva, D. V., Gorudko, I. V., Kozlov, S. O., Kudryavtsev, I. V., Mikhalchik, E. V., Filatov, M. V., Cherenkevich, S. N., et al. (2018) · Biochemistry and Cell Biology · doi:10.1139/bcb-2017-0277 · Cited by 13
Iron, the Essential Micronutrient: A Comprehensive Review of Regulatory Pathways of Iron Metabolism
Horváth, A., Tamási, K., Pap, R., Jánosa, G., & Pandur, E. (2025) · Nutrients · doi:10.3390/nu18010109 · Cited by 12
Isah, M. B., Goldring, J. P. D., & Coetzer, T. H. T. (2019) · Molecular and Biochemical Parasitology · doi:10.1016/j.molbiopara.2019.111245 · Cited by 12
Sofer, T., Li, R., Joehanes, R., Lin, H., Gower, A. C., Wang, H., Kurniansyah, N., Cade, B. E., Lee, J., Williams, S., et al. (2020) · EBioMedicine · doi:10.1016/j.ebiom.2020.102803 · Cited by 12
Fosset, C., Danzeisen, R., Gambling, L., McGaw, B. A., & McArdle, H. J. (2009) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2009.01.007 · Cited by 12
Putative Biomarker Genes for Grading Clear Cell Renal Cell Carcinoma
Maruschke, M., Koczan, D., Reuter, D. A., Ziems, B., Nizze, H., Hakenberg, O. W., & Thiesen, H.-J. (2011) · Urologia Internationalis · doi:10.1159/000328196 · Cited by 12
Jie, Y.-K., Cheng, C.-H., Ma, H., Liu, G., Fan, S., Jiang, J., & Guo, Z. (2022) · Antioxidants · doi:10.3390/antiox12010076 · Cited by 11
Metadata
- Authors
- Mukhopadhyay, C. K., Mazumder, B., & Fox, P. L.
- Affiliations
- Cleveland Clinic (US)
- Corresponding author
- Fox, Paul L.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2000-07
- Volume
- 275
- Issue
- 28
- Pages
- 21048-21054
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2030992731
- Cited by
- 274
- References
- 68
- Citations by year
- 2025: 2 · 2024: 7 · 2023: 12 · 2022: 7 · 2021: 11 · 2020: 11 · 2019: 6 · 2018: 9 · 2017: 3 · 2016: 10 · 2015: 7 · 2014: 10 · 2013: 16 · 2012: 13
- FWCI
- 8.15
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- National Heart, Lung, and Blood Institute (HL 29582, P01HL029582)
- Topics
- Health Sciences › Medicine › Hematology › Iron Metabolism and Disorders
- Health Sciences › Medicine › Hematology › Erythropoietin and Anemia Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Heme Oxygenase-1 and Carbon Monoxide
- Keywords
- ceruloplasmin, HIF-1, iron deficiency, transcriptional activation, hypoxia response element, HIF-1α, ARNT, iron metabolism, anemia, HepG2 cells, iron chelators
- MeSH terms
- Anemia, Animals, Base Sequence, Ceruloplasmin, Cloning, Molecular, DNA-Binding Proteins, Enhancer Elements, Genetic, Erythropoietin, Female, Gene Expression Regulation, Carcinoma, Hepatocellular, Humans, Liver Neoplasms, Molecular Sequence Data, Nuclear Proteins, Pregnancy, Promoter Regions, Genetic, Recombinant Proteins, Transcription Factors, Transfection, Tumor Cells, Cultured, Transcriptional Activation, Consensus Sequence, Sequence Alignment, Anemia, Iron-Deficiency, Mice, Hypoxia-Inducible Factor 1, Hypoxia-Inducible Factor 1, alpha Subunit
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review